Conditions: Neoplasms
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 50
Healthy volunteers: no

Brief summary:
The primary objective of this trial is to evaluate the efficacy and safety of BI 6727 in patients with locally advanced, metastatic or recurrent urothelial cancer after failure of first line or adjuvant/neoadjuvant chemotherapy.

Detailed description:

Arms:
arm 1: open label

Interventions: intervention 1: BI 6727, IV infusion
Intervention descriptions: intervention 1: phase II

Protocol document: